...
首页> 外文期刊>Journal of pharmacological sciences. >Combination of leukotoriene receptor antagonist with antihistamine has an additive suppressive effect on the up-regulation of H1-receptor mRNA in the nasal mucosa of toluene 2,4-diisocyanate-sensitized rat
【24h】

Combination of leukotoriene receptor antagonist with antihistamine has an additive suppressive effect on the up-regulation of H1-receptor mRNA in the nasal mucosa of toluene 2,4-diisocyanate-sensitized rat

机译:白三烯受体拮抗剂与抗组胺药合用对甲苯2,4-二异氰酸酯致敏大鼠鼻黏膜中H1-受体mRNA的上调具有累加抑制作用

获取原文
获取原文并翻译 | 示例

摘要

An attempt was made to clarify the additive suppressive effects of pranlukast, a cysteinyl leukotriene-receptor (LTR) antagonist, in combination with chlorpheniramine, an antihistamine, on the up-regulation of histamine H1-receptor (H1R) mRNA in toluene 2,4-diisocyanate (TDI)-sensitized rats. Although pre-treatment with pranlukast partially, but significantly, suppressed TDI-induced up-regulation of H1R mRNA and nasal symptoms, pre-treatment with the combination of pranlukast and chlorpheniramine significantly suppressed them in a manner greater than either drug alone. These findings suggest that the additive therapeutic effect of the combination of LTR antagonist and antihistamine is due to their additive suppression of H1R up-regulation.
机译:试图阐明半胱氨酰白三烯受体(LTR)拮抗剂普鲁司特与抗组胺氯苯那敏联用对甲苯2,4中组胺H1受体(H1R)mRNA上调的累加抑制作用-二异氰酸酯(TDI)致敏的大鼠。尽管用普鲁司特进行的预处理部分但显着抑制了TDI诱导的H1R mRNA和鼻部症状的上调,但与普鲁司特和氯苯那敏联合使用的预处理明显抑制了它们,其作用远大于单独使用任何一种药物。这些发现表明,LTR拮抗剂和抗组胺药的组合的累加治疗作用是由于它们对H1R上调的累加抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号